NervGen Pharma Corp. (NGENF)
OTCMKTS
· Delayed Price · Currency is USD
2.725
+0.145 (5.62%)
Jul 9, 2025, 4:00 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $197.19 million as of July 10, 2025. Its market cap has increased by 58.98% in one year.
Market Cap
197.19M
Enterprise Value
186.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.73
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 37.55M to 197.19M, an increase of 425.17%. That is a compound annual growth rate of 29.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.62B |
Veradigm | 840.66M |
Nika Pharmaceuticals | 708.22M |
Elite Pharmaceuticals | 661.21M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 536.01M |
American Oncology Network | 433.75M |
CytoDyn | 398.52M |